Dr Steve Assinder
Position:
- Lecturer in Physiology, Physiology and Andrology Research Group , University of Sydney
- Head, Bosch Institute (Bosch Prostate Cancer Focus Group)
Websites:
- http://www.bosch.org.au/research/CancerCellBiolDev/BPCFG/index.php
- http://www.medfac.usyd.edu.au/people/academics/profile/sassinder.php
Biography:
Dr Assinder's work is concerned with three main areas: the role of oxytocin in prostate disease; actin-binding proteins in regulation of the cytoskeleton and their roles in prostate cancer; and the ingeration of the AKT, PTEN and TGF-b pathways. This work is in collaboration with Profs Des Richardson and Qihan Dong, co-members of the Bosch Prostate Cancer Focus Group.
Current Areas of Collaboration: integration of cell signal pathways and pharmocological targeting; diagnostic and prognostic marker discovery.
AKT, NDRG-1, PTEN, TGF-beta, cancer initiation, cancer progression, genes/genetic polymorphisms, localized therapies, marker discovery, metastases, normal functioning, oncogenes and tumour suppressor genes, oxytocin, technology development, transgelin, tropomyosin.
